Neurocrine Biosciences Inc
2019 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/10/2026 | 5,885 | 0.1% | 41,495 | 12/31/2025 |
| 2025 Q3 | 10/31/2025 | 6,430 | 0.1% | 45,806 | 9/30/2025 |
| 2025 Q2 | 7/29/2025 | 6,186 | 0.1% | 49,217 | 6/30/2025 |
| 2025 Q1 | 5/9/2025 | 5,676 | 0.1% | 51,317 | 3/31/2025 |
| 2024 Q4 | 2/5/2025 | 7,300 | 0.1% | 53,482 | 12/31/2024 |
| 2024 Q3 | 11/6/2024 | 6,288 | 0.1% | 54,573 | 9/30/2024 |
| 2024 Q2 | 8/9/2024 | 7,933 | 0.1% | 57,621 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 8,177 | 0.1% | 59,290 | 3/31/2024 |
| 2023 Q4 | 1/26/2024 | 7,995 | 0.1% | 60,681 | 12/31/2023 |
| 2023 Q3 | 11/9/2023 | 7,139 | 0.1% | 63,455 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 6,666 | 0.1% | 70,692 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 7,864 | 0.1% | 77,689 | 3/31/2023 |
| 2022 Q4 | 2/10/2023 | 9,430 | 0.1% | 78,952 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 8,160 | 0.1% | 76,826 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 7,789 | 0.1% | 79,906 | 6/30/2022 |
| 2022 Q1 | 5/2/2022 | 8,110 | 0.1% | 86,504 | 3/31/2022 |
| 2021 Q4 | 2/3/2022 | 7,225 | 0.1% | 84,832 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 8,002 | 0.1% | 83,430 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 8,098 | 0.1% | 83,206 | 6/30/2021 |
| 2021 Q1 | 5/13/2021 | 8,205 | 0.1% | 84,372 | 3/31/2021 |
| 2020 Q3 | 11/13/2020 | 115 | 0.0% | 1,195 | 9/30/2020 |
| 2020 Q2 | 8/6/2020 | 146 | 0.0% | 1,195 | 6/30/2020 |
| 2020 Q1 | 5/11/2020 | 1,448 | 0.0% | 16,727 | 3/31/2020 |
| 2019 Q4 | 2/11/2020 | 2,750 | 0.0% | 25,581 | 12/31/2019 |